Trust Co. of Vermont Sells 258 Shares of Cardinal Health, Inc. (NYSE:CAH)

Trust Co. of Vermont lessened its holdings in Cardinal Health, Inc. (NYSE:CAH) by 4.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,039 shares of the company’s stock after selling 258 shares during the period. Trust Co. of Vermont’s holdings in Cardinal Health were worth $596,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the business. Arkadios Wealth Advisors purchased a new stake in shares of Cardinal Health during the 4th quarter valued at about $242,000. Merit Financial Group LLC bought a new stake in Cardinal Health during the fourth quarter worth approximately $433,000. Avanza Fonder AB purchased a new stake in Cardinal Health during the fourth quarter valued at approximately $2,999,000. KMG Fiduciary Partners LLC lifted its stake in shares of Cardinal Health by 2.8% in the 4th quarter. KMG Fiduciary Partners LLC now owns 79,977 shares of the company’s stock valued at $9,459,000 after purchasing an additional 2,141 shares during the last quarter. Finally, Occidental Asset Management LLC boosted its holdings in shares of Cardinal Health by 10.1% in the 4th quarter. Occidental Asset Management LLC now owns 33,873 shares of the company’s stock worth $4,006,000 after purchasing an additional 3,102 shares during the period. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Performance

NYSE CAH opened at $126.27 on Friday. The company has a market cap of $30.56 billion, a PE ratio of 24.57, a P/E/G ratio of 1.48 and a beta of 0.63. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $127.27. The firm’s 50 day moving average price is $120.75 and its 200-day moving average price is $111.92.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. The business had revenue of $52.28 billion for the quarter, compared to the consensus estimate of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The business’s revenue was down 4.3% compared to the same quarter last year. During the same period last year, the business posted $1.73 EPS. On average, analysts forecast that Cardinal Health, Inc. will post 7.82 earnings per share for the current fiscal year.

Cardinal Health Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd were given a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a dividend yield of 1.60%. The ex-dividend date of this dividend was Thursday, January 2nd. Cardinal Health’s payout ratio is 39.30%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on CAH. Evercore ISI upgraded Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target for the company in a research report on Tuesday, January 7th. StockNews.com cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd. Mizuho assumed coverage on shares of Cardinal Health in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 price objective on the stock. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Cardinal Health from $119.00 to $124.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Finally, Citigroup upped their target price on Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research note on Friday, January 10th. Four equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average price target of $133.29.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.